Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment

Worsening renal function in patients with baseline renal impairment treated with intravenous voriconazole: A systematic review

(2015) R. Brigg Turner et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Impact of Intravenous Administration of Voriconazole in Critically Ill Patients with Impaired Renal Function

(2014) F. Álvarez-Lerma et al.   JOURNAL OF CHEMOTHERAPY

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation

(2014) Andreas H Groll et al.   LANCET ONCOLOGY

Evaluation of intravenous voriconazole in patients with compromised renal function

(2013) Craig M Lilly et al.   BMC INFECTIOUS DISEASES

Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis

(2013) Seyedmojtaba Seyedmousavi et al.   Expert Review of Anti-Infective Therapy

Safety and Tolerability of Voriconazole in Patients with Baseline Renal Insufficiency and Candidemia

(2012) A. M. L. Oude Lashof et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Administration of Voriconazole in Patients With Renal Dysfunction

(2012) D. Neofytos et al.   CLINICAL INFECTIOUS DISEASES

The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial

(2012) Wan Beom Park et al.   CLINICAL INFECTIOUS DISEASES

Antifungal prophylaxis in haematology patients: the role of voriconazole

(2012) Y. Hicheri et al.   CLINICAL MICROBIOLOGY AND INFECTION

Cyclodextrins

(2012) Sergey V. Kurkov et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients

(2011) Si-Hyun Kim et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Pharmacokinetics of sulfobutylether- -cyclodextrin (SBECD) in subjects on hemodialysis

(2011) D. R. Luke et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Pharmacokinetics of Sulfobutylether-Beta-Cyclodextrin and Voriconazole in Patients with End-Stage Renal Failure during Treatment with Two Hemodialysis Systems and Hemodiafiltration

(2010) V. Hafner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study

(2010) Pavlos Myrianthefs et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Review of the Basic and Clinical Pharmacology of Sulfobutylether-β-Cydodextrin (SBECD)

(2010) David R. Luke et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Voriconazole concentrations and outcome of invasive fungal infections

(2009) S. Miyakis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications

(2008) D. Andes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics, Safety and Tolerance of Voriconazole in Renally??Impaired Subjects

(2008) Samantha Abel et al.   CLINICAL DRUG INVESTIGATION

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

(2008) Brahm H. Segal et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Cyclodextrins

(2008) Valentino J. Stella et al.   TOXICOLOGIC PATHOLOGY

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES